Skip to main content
. 2025 Jul 21;11(4):01007-2024. doi: 10.1183/23120541.01007-2024

TABLE 5.

Reporting the instruments used to measure the outcomes reported in this scoping review

Outcome domain Outcome Measurement instruments per outcome n (%)
Mortality/survival Survival _
Physiological/clinical Cough strength (e.g. peak cough flow) Peak flow meter 22 (46)
Pneumotachograph 15 (31)
Spirometer 14 (29)
Flow analyser 2 (4)
Plethysmography 1 (2)
Not reported 1 (2)
Lung volume (e.g. vital capacity, forced vital capacity, forced expiratory volume, expiratory reserve volume) Spirometer 32 (67)
Pneumotachograph 10 (21)
Plethysmography 3 (6)
Electrical impedance tomography 3 (6)
Flow analyser 1 (2)
Helium dilation 1 (2)
Not reported 3 (6)
Insufflation capacity (e.g. maximum insufflation capacity, lung insufflation capacity) Spirometer 14 (64)
Pneumotachograph 5 (23)
Plethysmography 2 (9)
Flow analyser 1 (5)
Helium dilation 1 (5)
Calculation from ventilator 1 (5)
Oxygen levels (e.g. saturation of peripheral oxygen) Transcutaneous monitor 13 (87)
Plethysmography 1 (7)
Polysomnography 1 (7)
Air flow (e.g. peak expiratory flow, forced expiratory flow) Spirometer 8 (62)
Pneumotachograph 3 (23)
Peak flow meter 2 (15)
Plethysmography 1 (8)
Respiratory muscle strength (e.g. maximal inspiratory pressure, maximal expiratory pressure, sniff nasal inspiratory pressure) Manometer 10 (63)
Electrometer 2 (13)
Not described 4 (25)
Respiratory rate Pneumotachograph 4 (50)
Plethysmography 2 (25)
Electrical impedance tomography 1 (13)
Spirometer 1 (13)
Transcutaneous monitor 1 (13)
Airway pressure (e.g. peak inspiratory pressure, peak expiratory pressure, transpulmonary pressure) Manometer 3 (100)
Carbon dioxide levels Transcutaneous monitor 3 (50)
Capnography monitor 3 (50)
Lung expansion/compliance Pneumotachograph 2 (40)
Manometer 2 (40)
Spirometer 1 (20)
Pulse method 1 (20)
From a previous study – unable to obtain details 1 (20)
Heart rate Transcutaneous monitor 2 (40)
Photoplethysmography 1 (20)
Electrocardiogram 1 (20)
Not reported 1 (20)
Cough volume Spirometer 2 (100)
Pneumotachograph 1 (50)
Mean arterial pressure Photoplethysmography 2 (100)
Airway resistance Oscilloresistometry 1 (50)
Plethysmography 1 (50)
Airway collapsibility Spirometer 1 (100)
Sputum weight Balance 1 (100)
Global quality of life Quality of life 36-Item Short Form Survey 2 (67)
Sickness impact profile 1 (33)
Assessment of quality of life 8-dimension 1 (33)
Severe respiratory insufficiency questionnaire 1 (33)
Sleep apnoea quality of life index 1 (33)
Functioning Breathlessness Borg scale 2 (67)
Baseline dyspnoea Index/transitional dyspnoea index 1 (33)
Impact on functional ability Amyotrophic lateral sclerosis functional rating scale - revised 2 (67)
Amyotrophic lateral sclerosis assessment questionnaire 5 1 (33)
Fatigue Fatigue severity scale 1 (100)
Delivery of care Comfort Visual analogue scale 5 (83)
Visual numeric scale 1 (17)
Patient satisfaction Questionnaire/survey 3 (75)
Visual analogue scale 1 (25)
Patient-reported cough strength Visual analogue scale 2 (100)
Patient-reported effectiveness of secretion clearance Visual analogue scale 1 (100)
Impact of delivering secretion clearance technique on caregiver Caregiver strain index 1 (50)
Purposely designed survey 1 (50)
Adherence to secretion clearance techniques Diary 2 (67)
Caregivers therapy adherence questionnaire 1 (33)
Lung volume recruitment counter 1 (33)

Data are presented as n (%). Proportions do not always sum to 100% as multiple instruments were used in some studies to measure the same outcome and some studies do not report which measurement instruments were utilised. The denominators for the calculation are the number of studies who reported using the outcome.